Literature DB >> 18762984

Antiprotozoan activity of Brazilian marine cnidarian extracts and of a modified steroid from the octocoral Carijoa riisei.

Juliana Quero Reimão1, Alvaro Esteves Migotto, Miriam H Kossuga, Roberto G S Berlinck, André Gustavo Tempone.   

Abstract

In the present investigation, we have evaluated the antileishmanial and antitrypanosomal activity of methanolic crude extracts obtained from eight species of cnidarians and of a modified steroid isolated from the octocoral Carijoa riisei. The antileishmanial activity of cnidarians crude extracts showed 50% inhibitory concentration (IC50) values in the concentration range between 2.8 and 93.3 microg/mL. Trypomastigotes of Trypanosoma cruzi were less susceptible to the crude extracts, with IC50 values in the concentration range between 40.9 and 117.9 microg/mL. The steroid (18-acetoxipregna-1,4,20-trien-3-one) displayed a strong antileishmanial activity, with an IC50 value of 5.5 microg/mL against promastigotes and 16.88 microg/mL against intracellular amastigotes. The steroid also displayed mammalian cytotoxicity (IC50 of 10.6 microg/mL), but no hemolytic activity was observed at the highest concentration of 12.5 microg/mL. The antileishmanial effect of the steroid in macrophages suggested other mechanism than macrophage activation, as no upregulation of nitric oxide was observed. The antitrypanosomal activity of the steroid resulted in an IC50 value of 50.5 microg/mL. These results indicate the potential of cnidarian natural compounds as antileishmanial drug candidates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762984     DOI: 10.1007/s00436-008-1154-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  24 in total

1.  Isolation and structure elucidation of new cytotoxic steroids from the gorgonian Leptogorgia sarmentosa.

Authors:  L Garrido; E Zubía; M J Ortega; J Salvá
Journal:  Steroids       Date:  2000-02       Impact factor: 2.668

Review 2.  Pharmacological approaches to antitrypanosomal chemotherapy.

Authors:  S L Croft
Journal:  Mem Inst Oswaldo Cruz       Date:  1999 Mar-Apr       Impact factor: 2.743

Review 3.  Marine natural products.

Authors:  D John Faulkner
Journal:  Nat Prod Rep       Date:  2002-02       Impact factor: 13.423

4.  Access to essential drugs in poor countries: a lost battle?

Authors:  B Pécoul; P Chirac; P Trouiller; J Pinel
Journal:  JAMA       Date:  1999-01-27       Impact factor: 56.272

5.  Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages.

Authors:  Filomena M Perrella Balestieri; Allan R Pires Queiroz; Cristoforo Scavone; Vlaudia M Assis Costa; Manoel Barral-Netto; Ises de Almeida Abrahamsohn
Journal:  Microbes Infect       Date:  2002-01       Impact factor: 2.700

Review 6.  Chagas disease.

Authors:  A R L Teixeira; N Nitz; M C Guimaro; C Gomes; C A Santos-Buch
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 7.  Chemotherapy of leishmaniasis.

Authors:  Simon L Croft; Vanessa Yardley
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

8.  New cytotoxic sterol glycosides from the octocoral Carijoa (Telesto) riisei.

Authors:  L F Maia; R A Epifanio; W Fenical
Journal:  J Nat Prod       Date:  2000-10       Impact factor: 4.050

9.  Antimicrobial activity in the common seawhip, Leptogorgia virgulata (Cnidaria: Gorgonaceae).

Authors:  Jacqueline L Shapo; Peter D Moeller; Sylvia B Galloway
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2007-05-05       Impact factor: 2.231

10.  In vitro trypanocidal activity of tetraethylthiuram disulfide and sodium diethylamine-N-carbodithioate on Trypanosoma cruzi.

Authors:  J E Lane; R Ribeiro-Rodrigues; C C Suarez; B J Bogitsh; M M Jones; P K Singh; C E Carter
Journal:  Am J Trop Med Hyg       Date:  1996-09       Impact factor: 2.345

View more
  8 in total

1.  Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study.

Authors:  Juliana Quero Reimão; Noemi Nosomi Taniwaki; André Gustavo Tempone
Journal:  Parasitol Res       Date:  2010-03-30       Impact factor: 2.289

2.  Molluscicidal activity of some marine substances against the snail Biomphalaria glabrata (Mollusca, Planorbidae).

Authors:  P A Miyasato; T Kawano; J C Freitas; R G S Berlinck; E Nakano; L F Tallarico
Journal:  Parasitol Res       Date:  2011-12-29       Impact factor: 2.289

3.  Isolation, Derivative Synthesis, and Structure-Activity Relationships of Antiparasitic Bromopyrrole Alkaloids from the Marine Sponge Tedania brasiliensis.

Authors:  Lizbeth L L Parra; Ariane F Bertonha; Ivan R M Severo; Anna C C Aguiar; Guilherme E de Souza; Glaucius Oliva; Rafael V C Guido; Nathalia Grazzia; Tábata R Costa; Danilo C Miguel; Fernanda R Gadelha; Antonio G Ferreira; Eduardo Hajdu; Daniel Romo; Roberto G S Berlinck
Journal:  J Nat Prod       Date:  2018-01-03       Impact factor: 4.050

Review 4.  Cnidarians as a potential source of antiparasitic drugs.

Authors:  Osama Mostafa; Mohammed Al-Shehri; Mahmoud Moustafa; Ahmed Al-Emam
Journal:  Parasitol Res       Date:  2021-11-29       Impact factor: 2.289

5.  Antifungal compounds with anticancer potential from Trichoderma sp. P8BDA1F1, an endophytic fungus from Begonia venosa.

Authors:  Diana F Grigoletto; Daniela B B Trivella; André G Tempone; André Rodrigues; Ana Maria L Correia; Simone P Lira
Journal:  Braz J Microbiol       Date:  2020-04-24       Impact factor: 2.476

Review 6.  Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications.

Authors:  Gian Luigi Mariottini; Luigi Pane
Journal:  Toxins (Basel)       Date:  2013-12-27       Impact factor: 4.546

Review 7.  Antimicrobials from Cnidarians. A New Perspective for Anti-Infective Therapy?

Authors:  Gian Luigi Mariottini; Irwin Darren Grice
Journal:  Mar Drugs       Date:  2016-03-08       Impact factor: 5.118

Review 8.  Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.

Authors:  María Álvarez-Bardón; Yolanda Pérez-Pertejo; César Ordóñez; Daniel Sepúlveda-Crespo; Nestor M Carballeira; Babu L Tekwani; Sankaranarayanan Murugesan; Maria Martinez-Valladares; Carlos García-Estrada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Mar Drugs       Date:  2020-03-31       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.